Federal prosecutors want to increase to 17-1/2 years the time that a founder and supervisory pharmacist of a Massachusetts compounding pharmacy each spend in prison after its tainted drugs sparked 2012’s deadly fungal meningitis outbreak.
Prosecutors made their recommendations in filings on Friday after the 1st U.S. Circuit Court of Appeals ordered the re-sentencing of Barry Cadden, New England Compounding Center’s ex-president, and Glenn Chin, its former supervisory pharmacist.
To read the full story on Westlaw Today, click here: bit.ly/33aZK8q
Our Standards: The Thomson Reuters Trust Principles.